Selection, design, and characterization of a new potentially therapeutic ribozyme.
about
Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyCharacterization of long RNA-cleaving deoxyribozymes with short catalytic cores: the effect of excess sequence elements on the outcome of in vitro selection.Computational approaches toward the design of pools for the in vitro selection of complex aptamers.In vitro RNA random pools are not structurally diverse: a computational analysis.Screening mutant libraries of T7 RNA polymerase for candidates with increased acceptance of 2'-modified nucleotides.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.Therapeutic regulation of gene expression in the inner ear using RNA interference.Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers.Substrate specificity and kinetic framework of a DNAzyme with an expanded chemical repertoire: a putative RNaseA mimic that catalyzes RNA hydrolysis independent of a divalent metal cation.Efficient knockdown of human prnp mRNA expression levels using hybrid hammerhead ribozymes.Identification of a pKa-regulating motif stabilizing imidazole-modified double-stranded DNA.Substrate specificity and reaction kinetics of an X-motif ribozyme.Synthesis and transcription studies on 5'-triphosphates derived from 2'-C-branched-uridines: 2'-homouridine-5'-triphosphate is a substrate for T7 RNA polymerase.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.Modified nucleoside triphosphates: synthesis and applications for RNA in vitro selection.
P2860
Q27025832-23EE7861-A9E7-4B4E-A3B1-2A611EFBCB7BQ33242772-E96586F2-FB4D-4FB6-85BA-C39C122A5913Q33703493-3ECDAF57-3DBF-47B0-9D74-22CA43C27C72Q34366408-04B3F731-0304-4656-957E-2002858055D6Q34397679-09B61E12-EFCF-44DF-A5FB-281B51F089ACQ36918516-AB3E8FB1-872E-44F1-BEBF-533B28444D37Q37507085-CB07F42A-9AA9-4C0D-879D-0F0DEF42A766Q37967636-E6CFB443-E925-4469-819F-60ADB54D377DQ38332536-870A18F1-74CD-4E57-8C5B-8B5F4CE5FC7EQ39810017-312538D1-BF39-4E86-901B-C16DAD1A01D8Q41906010-087EEDC2-F301-42D8-B09B-8D28E1A4F833Q43207089-11E59DA7-96BB-4A88-AD25-4D8F89A37E25Q44790900-75768F9E-04CF-4E22-BC88-DAD126C7CF84Q48263612-FE402C77-2C94-4C1A-B770-7469257CC57AQ52948796-DB6E4436-2832-4A15-9073-BA321B0819CE
P2860
Selection, design, and characterization of a new potentially therapeutic ribozyme.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@ast
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@en
type
label
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@ast
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@en
prefLabel
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@ast
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@en
P2093
P2860
P1433
P1476
Selection, design, and characterization of a new potentially therapeutic ribozyme.
@en
P2093
Alex Burgin
Amber Beaudry
Andrew T Daniher
Brent A Dickinson
Kristal Domenico
Leonid Beigelman
Mike Wilson
Shawn P Zinnen
Victor Mokler
P2860
P304
P356
10.1017/S1355838202014723
P407
P577
2002-02-01T00:00:00Z